Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

RISDIPLAM vs RISEDRONATE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

RISDIPLAM vs RISEDRONATE: Safety Overview

Metric RISDIPLAM RISEDRONATE
Total FAERS Reports 3,619 6,768
Deaths Reported 336 202
Death Rate 9.3% 3.0%
Hospitalizations 719 1,825
Average Patient Age 21.8 yrs 68.0 yrs
% Female Patients 55.2% 92.3%
FDA Approval Date Aug 7, 2020 Apr 14, 2000
Manufacturer Genentech, Inc. Aurobindo Pharma Limited
Route ORAL ORAL
Marketing Status Prescription Discontinued